The Future of the Pharmaceutical Industry's Hold on Intellectual Property Rights
Generic competitors may be free to create more economical options as patent protections on notable brand-name drugs begin to expire at the end of the decade.
Volume 20, Issue 9
Generic competitors may be free to create more economical options as patent protections on notable brand-name drugs begin to expire at the end of the decade.
Based on several years of nurse review and investigation into whistleblower allegations by the government and private whistleblowers.